VR

Veerabhadra Rao Mandalapu

Active Director Director DIN 10639425
DIN 10639425 First appointment May 2024 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Veerabhadra Rao Mandalapu

Data last updated:

Veerabhadra Rao Mandalapu is a Director at Medistax Laboratories Private Limited (since 2024). The company operates in Paper.

DIN 10639425
Primary Designation Director
Industry Paper
First Appointment 22 May 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director22 May 20242024Active

Board colleagues of Veerabhadra Rao Mandalapu

NameDINCompanyDesignation
Mohan Seshu Obillineni10639424Medistax Laboratories Private LimitedDirector

Directorship timeline

Open interactive timeline →
Medistax Laboratories Private Limited
Premium access

Shareholding and investment profile for Veerabhadra Rao Mandalapu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Veerabhadra Rao Mandalapu

Veerabhadra Rao Mandalapu currently holds 1 directorship: Medistax Laboratories Private Limited (Director, since 22 May 2024).

Veerabhadra Rao Mandalapu was first appointed on 22 May 2024 as Director at Medistax Laboratories Private Limited.

The current boards of Veerabhadra Rao Mandalapu's companies include Mohan Seshu Obillineni (Medistax Laboratories Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available